Summit Therapeutics (SMMT) Return on Capital Employed (QoQ) (2021 - 2024)

Summit Therapeutics (SMMT) Return on Capital Employed (QoQ) (2021 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Summit Therapeutics 11.62 Bn 11.03 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 124.00
Sep 30, 2024 7,909.00
Jun 30, 2024 -6,417.00
Mar 31, 2024 25,132.00
Dec 31, 2023 19,964.00
Sep 30, 2023 -26,800.00
Jun 30, 2023 -11,920.00
Mar 31, 2023 -11,336.00
Dec 31, 2022 5,208.00
Sep 30, 2022 1,689.00
Jun 30, 2022 1,075.00
Mar 31, 2022 -881.00
Dec 31, 2021 -2,762.00
Sep 30, 2021 -570.00
Jun 30, 2021 6,805.00
Mar 31, 2021 -1,699.00